What will Eli Lilly say during their next earnings call?

As of Tue, 20 Oct 2026 12:54:44 UTC, Kalshi traders price Inluriyo (82.0%), Foundayo (73.0%), Alzheimer (71.0%). The market has $1K in volume and closes on Thu, 12 Nov 2026.

Updated:

Current odds

OutcomeChanceYes priceNo price
Inluriyo82.0%82.0¢18.0¢
Foundayo73.0%73.0¢27.0¢
Alzheimer71.0%71.0¢29.0¢
LillyDirect69.0%69.0¢31.0¢
Jaypirca68.0%68.0¢32.0¢
China (5+ times)41.0%41.0¢59.0¢
Vial41.0%41.0¢59.0¢
ESMO37.0%37.0¢63.0¢
Headwind37.0%37.0¢63.0¢
Omvoh37.0%37.0¢63.0¢
Tariff37.0%37.0¢63.0¢
Ventyx37.0%37.0¢63.0¢
AI / Artificial Intelligence36.0%36.0¢64.0¢
Novo Nordisk36.0%36.0¢64.0¢
Nvidia36.0%36.0¢64.0¢

Market details

Resolution rules

Each outcome is a separate contract with its own rules. The rules for Inluriyo:

If Inluriyo is said by any Eli Lilly and Company representative (including the operator of the call) during the next Eli Lilly and Company live earnings call or official broadcast (including the Q+A), then the market resolves to Yes. How this is resolved Video of the Eli Lilly and Company earnings call. If a consensus by Kalshi employees cannot be reached using video, transcripts of the Eli Lilly and Company earnings call will be used according to the news publications listed in the contract. Payout criteria The exact phrase/word, or a plural or possessive form of the phrase/word. Doesn't count for payout Grammatical/tense inflections. Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company. All trademarks, logos, and brand names are the property of their respective owners.

Sources

Related markets

DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.